ISPC Key Statistics, Chart & Performance
The current stock price of ISPC is 0.3511 USD. In the past month the price increased by 34.99%. In the past year, price decreased by -82.36%.
ISPC Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to ISPC. When comparing the yearly performance of all stocks, ISPC is a bad performer in the overall market: 97.66% of all stocks are doing better.
ISPC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ISPC. ISPC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
ISPC Financial Highlights
Over the last trailing twelve months ISPC reported a non-GAAP Earnings per Share(EPS) of -6.95. The EPS increased by 63.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -128.18% | ||
| ROE | -375.34% | ||
| Debt/Equity | 0 |
ISPC Forecast & Estimates
For the next year, analysts expect an EPS growth of 10.23% and a revenue growth 11.76% for ISPC
ISPC Ownership
About ISPC
Company Profile
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. The company is headquartered in Woburn, Massachusetts and currently employs 24 full-time employees. The company went IPO on 2021-06-17. The firm addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Company Info
ISPECIMEN INC
8 Cabot Road, Suite 1800
Woburn MASSACHUSETTS US
CEO: Christopher Ianelli
Employees: 24
Phone: 17813016700
ISPECIMEN INC / ISPC FAQ
What does ISPECIMEN INC do?
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. The company is headquartered in Woburn, Massachusetts and currently employs 24 full-time employees. The company went IPO on 2021-06-17. The firm addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
What is the current price of ISPC stock?
The current stock price of ISPC is 0.3511 USD. The price increased by 6.72% in the last trading session.
Does ISPC stock pay dividends?
ISPC does not pay a dividend.
How is the ChartMill rating for ISPECIMEN INC?
ISPC has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
On which exchange is ISPC stock listed?
ISPC stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for ISPC stock?
ISPECIMEN INC (ISPC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-6.95).